Patents by Inventor Elena Sebokova

Elena Sebokova has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MARKER PROTEIN FOR TYPE-2 DIABETES
    Publication number: 20120276561
    Abstract: The present invention provides a marker protein for the early detection of type II diabetes, antibodies directed to the marker protein and their use in a diagnostic method for type II diabetes and in drug development.
    Type: Application
    Filed: November 23, 2010
    Publication date: November 1, 2012
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Laura Badi, Martin Ebeling, Hugues Matile, Cristiano Migliorini, Jacob Sabates Bellver, Thomas Schindler, Elena Sebokova, Haiyan Wang
  • Timp-2 as target/marker of beta cell failure
    Publication number: 20100009462
    Abstract: The present invention relates to the monitoring of disease progression and diagnosis of beta-cell failure in diabetes by measuring levels of TIMP-2 in a liquid sample, and to screening for novel compounds for the prevention and/or treatment of diabetes.
    Type: Application
    Filed: July 19, 2005
    Publication date: January 14, 2010
    Inventors: Andreas Christ, Stefan Evers, Kurt Krapfenbauer, Elena Sebokova
  • Pancreatic polypeptide as target/marker of beta cell failure
    Publication number: 20090215069
    Abstract: The present invention relates to the monitoring of disease progression and diagnosis of beta-cell failure in diabetes by measuring levels of pancreatic hormone in a liquid sample, and to screening for novel compounds for the prevention and/or treatment of diabetes.
    Type: Application
    Filed: July 19, 2005
    Publication date: August 27, 2009
    Inventors: Andreas Christ, Stefan Evers, Kurt Krapfenbauer, Elena Sebokova
  • Insulin promoter factor 1 as target/marker of beta cell failure
    Publication number: 20090208971
    Abstract: The present invention relates to the monitoring of disease progression and diagnosis of beta-cell failure in diabetes by measuring levels of IPF-1 in a liquid sample, and to screening for novel compounds for the prevention and/or treatment of diabetes.
    Type: Application
    Filed: July 19, 2005
    Publication date: August 20, 2009
    Inventors: Andreas Christ, Stefan Evers, Kurt Krapfenbauer, Elena Sebokova